Syntekabio Competitors and Similar CompaniesClear all
Syntekabio's competitors and similar companies include MOMA Therapeutics, Curebiotech, Transition Bio and Inotrem.
 Curebiotech CureBiotech is a company that provides intratumoral immunotherapy solutions for metastatic melanoma. |  Transition Bio Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis. |  Inotrem Inotrem is a biotech company specializing in the discovery and development of novel treatments in the field of inflammatory pathologies with a focus on critical care. | |||
Founding Date | Founding Date 2009 | Founding Date 2020 | Founding Date 2017 | Founding Date 2020 | Founding Date 2013 |
Type | Type Public | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Cambridge, US HQ Boston, US | Locations Ocean Beach, US HQ | Locations Cambridge, US HQ Cambridge, GB | Locations Paris, FR HQ Paris, FR Vandœuvre Lès Nancy, FR |
Employees | Employees N/A | Employees 67 | Employees 5 | Employees 2915% decrease | Employees N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 150m (about 4 years ago) | Latest funding round N/A | Latest funding round $ 50m (about 4 years ago) | Latest funding round $ 5.5m (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 236m | Total funding raised N/A | Total funding raised $ 50m | Total funding raised $ 71.6m |
For sources of this data, please see the company profile
View Company Profiles
MOMA Therapeutics
HQ
Cambridge, US
Employees
67
MOMA Therapeutics is a biotechnology company.
View companyCurebiotech
HQ
Ocean Beach, US
Employees
5
CureBiotech is a company that provides intratumoral immunotherapy solutions for metastatic melanoma.
View companyTransition Bio
HQ
Cambridge, US
Employees
29↓ 15% decrease
Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis.
View companyInotrem
HQ
Paris, FR
Inotrem is a biotech company specializing in the discovery and development of novel treatments in the field of inflammatory pathologies with a focus on critical care.
View company